Shuyun Rao
Overview
Explore the profile of Shuyun Rao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
844
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang X, Bhowmick K, Rao S, Xiang X, Ohshiro K, Amdur R, et al.
Cell Rep
. 2024 Sep;
43(9):114676.
PMID: 39217614
Obesity and fatty liver diseases-metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)-affect over one-third of the global population and are exacerbated in individuals with reduced functional aldehyde...
2.
Alvarez M, Benhammou J, Rao S, Mishra L, Pisegna J, Pajukanta P
Bio Protoc
. 2023 Mar;
13(3):e4601.
PMID: 36874905
Single-nucleus RNA sequencing (snRNA-seq) provides a powerful tool for studying cell type composition in heterogenous tissues. The liver is a vital organ composed of a diverse set of cell types;...
3.
Zaidi S, Amdur R, Xiang X, Yu H, Wong L, Rao S, et al.
Genes Cancer
. 2022 Jun;
13:9-20.
PMID: 35677836
Hepatocellular carcinoma (HCC) is the primary form of liver cancer and a major cause of cancer death worldwide. Early detection is key to effective treatment. Yet, early diagnosis is challenging,...
4.
Xiang X, Ohshiro K, Zaidi S, Yang X, Bhowmick K, Vegesna A, et al.
FASEB J
. 2022 May;
36(6):e22335.
PMID: 35506565
Dysregulated transforming growth factor-beta (TGF-β) signaling contributes to fibrotic liver disease and hepatocellular cancer (HCC), both of which are associated with fatty liver disease. SIRT6 limits fibrosis by inhibiting TGF-β...
5.
Benhammou J, Rich N, Cholankeril G, Zhang P, Zeng W, Rao S, et al.
Gastroenterology
. 2022 Mar;
163(1):21-27.
PMID: 35339460
No abstract available.
6.
Rao S, Yang X, Ohshiro K, Zaidi S, Wang Z, Shetty K, et al.
Sci Transl Med
. 2021 Dec;
13(624):eabk2267.
PMID: 34910547
The prevalence of nonalcoholic steatohepatitis (NASH) and liver cancer is increasing. De novo lipogenesis and fibrosis contribute to disease progression and cancerous transformation. Here, we found that β2-spectrin (SPTBN1) promotes...
7.
Wang Z, Hopson L, Singleton S, Yang X, Jogunoori W, Mazumder R, et al.
Biochim Biophys Acta Mol Basis Dis
. 2021 Jun;
1867(10):166179.
PMID: 34082069
Emerging data show a rise in colorectal cancer (CRC) incidence in young men and women that is often chemoresistant. One potential risk factor is an alteration in the microbiome. Here,...
8.
Zaidi S, Rao S, Mishra L
Gastroenterology
. 2020 Apr;
159(1):398-399.
PMID: 32289371
No abstract available.
9.
Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson L, Karasic T, et al.
Cancer Res
. 2019 Nov;
79(22):5897.
PMID: 31772073
No abstract available.
10.
Gu S, Zaidi S, Hassan M, Mohammad T, Malta T, Noushmehr H, et al.
Gastroenterology
. 2019 Oct;
158(1):238-252.
PMID: 31585122
Background & Aims: We studied interactions among proteins of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family, which interact with microbes, and transforming growth factor beta (TGFB) signaling pathway, which...